Document is current
Any future updates will be listed below
-
Authors
Yang, Chuang
Cheng, Wenke
Plum, Patrick S.
Lordick, Florian
Köppe, Jeanette
Gockel, Ines
Thieme, René
-
Funding
Funding for this research was provided by:
Universitätsklinikum Leipzig
- License Information
-
More Information
Article History
Received: 2 October 2024
Accepted: 31 March 2025
First Online: 8 April 2025
Declarations
:
: Florian Lordick: Honoraria: Lilly, Merck Sharp & Dohme, Bristol Myers Squibb, AstraZeneca, Elsevier, BioNTech, SERVIER, Merck KGaA, Roche, Medscape, Incyte, Art Tempi, Medupdate, Streamedup!, Daiichi Sankyo Europe GmbH, Novartis, Falk Foundation; Consulting or Advisory Role: AstraZeneca, Bayer AG, BioNTech SE, Merck KGaA, MSD Sharp & Dohme, Bristol Myers Squibb, Astellas Pharma, Zymeworks, Lilly Deutschland GmbH, Amgen, Daiichi Sankyo, Novartis, Elsevier GmbH, Falk Foundation e.V., Incyte Inc, Roche Deutschland Holding GbmH, Servier Deutschland GmbH, Springer Nature AG & Co. KGaA, StreamedUp! GmbH; Research Funding: Bristol Myers Squibb (Inst), Gilead Science GmbH.
: This research was conducted according to the principles expressed in the Declaration of Helsinki. The UK Biobank cohort has been approved by the North West Multicenter Research Ethics Committee, UK (Ref: 16/NW/0274). Written informed consent has been obtained from all study participants. The current study was approved by the UK Biobank access management board.
: Not applicable.
